The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2023

Filed:

Dec. 01, 2018
Applicant:

Ceeable, Inc., Somerville, MA (US);

Inventors:

Wolfgang Fink, Montrose, CA (US);

John Cerwin, Gurnee, IL (US);

Christopher P Adams, Somerville, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 3/113 (2006.01); A61B 5/16 (2006.01); A61B 3/00 (2006.01); A61B 3/024 (2006.01); A61B 3/08 (2006.01); A61B 3/117 (2006.01); A61B 3/12 (2006.01); A61B 5/00 (2006.01); G06F 3/01 (2006.01);
U.S. Cl.
CPC ...
A61B 3/113 (2013.01); A61B 3/0025 (2013.01); A61B 3/0041 (2013.01); A61B 3/0091 (2013.01); A61B 3/024 (2013.01); A61B 3/085 (2013.01); A61B 3/1176 (2013.01); A61B 3/12 (2013.01); A61B 5/161 (2013.01); A61B 5/162 (2013.01); A61B 5/163 (2017.08); A61B 5/165 (2013.01); A61B 5/4064 (2013.01); A61B 5/4094 (2013.01); A61B 5/4818 (2013.01); A61B 5/4845 (2013.01); A61B 5/6803 (2013.01); A61B 5/7267 (2013.01); A61B 5/7282 (2013.01); G06F 3/013 (2013.01);
Abstract

The present invention generally relates to apparatus, software and methods for assessing ocular, ophthalmic, neurological, physiological, psychological and/or behavioral conditions. As disclosed herein, the conditions are assessed using eye-tracking technology that beneficially eliminates the need for a subject to fixate and maintain focus during testing or to produce a secondary (non-optical) physical movement or audible response, i.e., feedback. The subject is only required to look at a series of individual visual stimuli, which is generally an involuntary reaction. The reduced need for cognitive and/or physical involvement of a subject allows the present modalities to achieve greater accuracy, due to reduced human error, and to be used with a wide variety of subjects, including small children, patients with physical disabilities or injuries, patients with diminished mental capacity, elderly patients, animals, etc.


Find Patent Forward Citations

Loading…